Li et al. discovered that the protein arginine methyltransferase 1 (PRMT1) catalyzes the asymmetric methylation of EZH2 to foster breast cancer proliferation, metastasis, and tumorigenesis [29,30]. This evidence concerns the gene PRMT1 and breast carcinoma.